A previous study demonstrates that AMPK downregulates carbamoyl phosphate synthase 1 (CPS1) in Kras-mutated non-small-cell lung cancer (NSCLC) cells [27]. Here, PRKAA1 is linked to non-small cell lung carcinoma.